ERG and prostate carcinoma: Prostate cancer and benign epithelial prostate cells overexpressing ERG display a characteristic invasivity in vitro [48], an effect that was most recently reversed using peptidomimetic inhibitors of ERG that were fused with a nuclear localization sequence (NLS) peptides to colocalize with ERG in the nucleus [54].